<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">bjcvs</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26934405</article-id><article-id pub-id-type="pmc">4762557</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20150081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>&#x003b1;-Smooth Muscle Actin and ACTA2 Gene Expressions in
Vasculopathies</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Shi-Min</given-names></name><degrees>MMed, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><aff id="aff1">The First Hospital of Putian, Teaching Hospital, Fujian Medical
University, Putian, China</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Adilia Maria Pires Sciarra, Faculdade de
Medicina de S&#x000e3;o Jos&#x000e9; do Rio Preto (FAMERP), Av. Brigadeiro Faria
Lima, 5416 - Vila S&#x000e3;o Pedro &#x02013; S&#x000e3;o Jos&#x000e9; do Rio Preto, SP,
Brazil &#x02013; Zip code: 15090-000. E-mail: <email>adilia@famerp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2015</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2015</year></pub-date><volume>30</volume><issue>6</issue><fpage>644</fpage><lpage>649</lpage><history><date date-type="received"><day>01</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>11</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the
Creative Commons Attribution License</license-p></license></permissions><abstract><p>&#x003b1;-smooth muscle actin, encoded by ACTA2 gene, is an isoform of the
vascular smooth muscle actins, typically expressed in the vascular smooth muscle
cells contributing to vascular motility and contraction. ACTA2 gene mutations
cause a diversity of diffuse vasculopathies such as thoracic aortic aneurysms
and dissections as well as occlusive vascular diseases, including premature
coronary artery disease and ischemic stroke. Dynamics of
differentiation-specific &#x003b1;-smooth muscle actin in arterial smooth muscle
cells and proliferation of the proteins have been well described. Although a
variety of research works have been undertaken in terms of modifications of
&#x003b1;-smooth muscle actin and mutations of ACTA2 gene and myosin, the
underlying mechanisms towards the pathological processes by way of gene
mutations are yet to be clarified. The purpose of the present article is to
describe the phenotypes of &#x003b1;-smooth muscle actin and implications of
ACTA2 mutations in vasculopathies in order to enhance the understanding of
potential mechanisms of aortic and coronary disorders.</p></abstract><kwd-group><kwd>Actins</kwd><kwd>Aorta, Thoracic</kwd><kwd>Mutation, Missense</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="float"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><thead><tr><th colspan="2" align="left" rowspan="1">
<bold>Abbreviations, acronyms &#x00026; symbols</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">ACTA2</td><td rowspan="1" colspan="1">= Actin, alpha 2, smooth muscle, aorta</td></tr><tr><td rowspan="1" colspan="1">bFGF</td><td rowspan="1" colspan="1">= Basic fibroblast growth factor</td></tr><tr><td rowspan="1" colspan="1">CAD</td><td rowspan="1" colspan="1">= Coronary artery disease</td></tr><tr><td rowspan="1" colspan="1">HH</td><td rowspan="1" colspan="1">= Hamburger - Hamilton stage</td></tr><tr><td rowspan="1" colspan="1">MYH11</td><td rowspan="1" colspan="1">= Myosin heavy chain 11</td></tr><tr><td rowspan="1" colspan="1">MYLK</td><td rowspan="1" colspan="1">= Myosin light chain kinase</td></tr><tr><td rowspan="1" colspan="1">PDGF</td><td rowspan="1" colspan="1">= Platelet derived growth factor</td></tr><tr><td rowspan="1" colspan="1">SMA</td><td rowspan="1" colspan="1">= a-smooth muscle actin</td></tr><tr><td rowspan="1" colspan="1">SMCs</td><td rowspan="1" colspan="1">= Smooth muscle cells</td></tr><tr><td rowspan="1" colspan="1">TAAD</td><td rowspan="1" colspan="1">= Thoracic aortic aneurysm and dissection</td></tr><tr><td rowspan="1" colspan="1">TGF</td><td rowspan="1" colspan="1">= Transforming growth factor</td></tr><tr><td rowspan="1" colspan="1">TGF-&#x003b2;<sub>1</sub></td><td rowspan="1" colspan="1">= Transforming growth factor beta 1</td></tr><tr><td rowspan="1" colspan="1">TGF&#x003b2;R1</td><td rowspan="1" colspan="1">= Transforming growth factor beta-receptor 1</td></tr><tr><td rowspan="1" colspan="1">TGF&#x003b2;R2</td><td rowspan="1" colspan="1">= Transforming growth factor beta-receptor 2</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The pathogenesis of vasculopathies, including aortic and coronary disorders, are
uncertain, even though they have been under constant investigation. The potential
roles that &#x003b1;-smooth muscle actin (SMA) might play in the development of
vasculopathies have drawn much attention.</p><p>SMA, encoded by ACTA2 gene, is an isoform of vascular SMA. The major functions of
vascular smooth muscle cells (SMCs) are typically vascular motility and contraction,
and the functions of certain non-muscle cells, such as myofibroblasts, are healing
wounds, scars and fibrocontractive lesions<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>, depending on the cyclic interaction between thin filaments
composed of the SMC-specific isoform of &#x003b1;-SMA encoded by ACTA2 and thick
filaments composed of SMC-specific &#x003b2;-myosin. &#x003b1;-SMA and the encoding
gene ACTA2 mutations have been frequently described in relation to pathogenesis of
vasculopathies in clinical settings<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Studies on ACTA2 mutations have demonstrated that mutation
carriers show various vasculopathies, including premature onset of coronary artery
disease (CAD), premature ischemic strokes (including Moyamoya disease), and familial
thoracic aortic aneurysms and dissections (TAADs)<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Proliferative and secretory activities as well as
transition from a contractile to a synthetic phenotype of &#x003b1;-SMA were
considered the underlying mechanism of vasculogenesis<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Experimental studies with explanted SMCs and
myofibroblasts from patients harboring ACTA2 revealed that increased proliferation
of SMCs contributed to occlusive diseases. Although a series of research works have
been undertaken in terms of &#x003b1;-SMA modifications and ACTA2 gene mutations, the
underlying mechanisms of pathological processes by way of mutations remain
underestimated. In order to highlight the potential mechanisms of pertinent
vasculopathies and to enhance management strategies, the phenotypes of &#x003b1;-SMA
and implications of ACTA2 mutations in vasculopathies are described.</p><sec><title>Molecular structure of &#x003b1;-SMA</title><p>There are four distinct variants of actins: two vascular SMC (&#x003b1;-SM and
&#x003b3;-SM)-specific, and two cytoplasmic actins (&#x003b2;-NM and &#x003b3;-NM
actins) in eukaryotic cells. &#x003b1;-SMA is located primarily in the
microfilament bundles of vascular SMCs and exerts contractile functions. It
shows a close relationship with arterial tones and the activation of
myofibroblasts<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The
forceful contractile property of myofibroblasts is attributable to the stress
fibers dependant on &#x003b1;-SMA<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. SMC components and extracellular matrix (collagen and
elastin) are determinants of the contractility, distensibility and elasticity of
the aortic wall. Extracellular matrix disruption or imbalance of the
extracellular matrix components leads to stiffness of the aortic wall and
further development of TAAD<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.
In experimental homozygous &#x003b1;-SMA knock-out mice, deficits of vascular
contractility and reduced basal blood pressure were noted, implicating the
important role of &#x003b1;-SMA in maintaining vascular tone<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p></sec><sec><title>Clinical investigations</title><p>Normal aortic media predominantly contains &#x003b1;-SMApositive SMCs with
homogeneous elastic laminae<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>
whereas degeneration is marked by disruptions of &#x003b1;-SMA-positive
SMCs<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Vascular
occlusions are pathologically characterized by medial proliferation of SMCs or
enhanced proteoglycan accumulation along with fragmentation and loss of elastic
fibers<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. The
&#x003b1;-SMA mutations in TAAD hinder the binding affinity between the monomer
and the ligands, thereby generating more unpolymerized monomers<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. The aortic media of
abdominal aortic aneurysm displays fewer &#x003b1;-SMA-positive cells, which are
secondary to extensive aortic wall structural damages. Medial SMC density may
decrease by 79.1% in abdominal aortic aneurysmal tissue in comparison with that
of normal control<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Aortic
aneurysmal wall shows chronic infiltration of the inflammatory cells,
degradation of the extracellular matrix, and apoptosis of SMCs<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. In addition, macrophages
express chemoattractant proteins and matrix metalloproteinases in the
atherosclerotic plaques<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>
similar to aortic aneurysm, in particular in the aneurysm necks for the stent
graft anchoring.</p><p>An immunohistological study has shown more &#x003b1;-SMA expressions in coronary
erosion lesions than in stable plaques or mildly stenotic plaques<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. Acute arterial injury was
found to be associated with changes in glycosaminoglycans of the extracellular
matrix ahead of those of SMC phenotype, whereby matrix glycosaminoglycans are
substituted by SMCs rapidly during the modification process where neointima does
not generate enough heparin sulphates<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>Coronary stenting may cause concentric narrowing of the lumen due to neointimal
formation, in which the extracellular matrix increases and number of SMCs
decreases over time. The neointima is composed of three-layered and
circular-arranged &#x003b1;-SMA-positive cells. Immunohistochemical studies of
the common carotid artery with stent deployment showed in-stent thrombus around
the stent struts with the neointima composed mainly of &#x003b1;-SMA-positive
cells within type I collagen-positive matrix<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Comparative studies on the abdominal
aortopathies revealed that &#x003b1;-SMA-positive SMCs were predominant in the
aortic media of the occlusive abdominal aorta and the aneurysmal neck; however,
SMCs were disrupted and disarrayed in the aneurysmal body, in which much fewer
SMCs were present than in the occlusive aorta and the aneurysmal neck<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>Transforming growth factor (TGF)-&#x003b2;-antagonist reduces &#x003b1;-SMA
expression, and treatment with TGF-&#x003b2; may upregulate &#x003b1;-SMA
expression. TGF-&#x003b2;<sub>1</sub>-stimulated adventitial fibroblasts in TAAD
patients attenuated extracellular matrix production and SMC
transformation<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In
the aneurysmal neck, there was increased TGF-&#x003b2;<sub>1</sub> expression and
reduced SMC density, and even more upregulated TGF-&#x003b2;<sub>1</sub>
expression and much more reduced SMC density were found in the aneurysmal body
in comparison with those of the occlusive aorta. Therefore, a link between
TGF-&#x003b2;<sub>1</sub> overexpression and reduced SMC density as a result
of SMC apoptosis and attenuated SMC proliferative capability may characterize
the aneurysmal formation<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p></sec><sec><title>Genetic aspects of ACTA2 mutations</title><p>ACTA2, the encoding gene of &#x003b1;-SMA, located at 10q22-q24 and composed of
eight coding exons, is a major contractile component of the arterial
SMCs<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. ACTA2 gene
defects that cause familial TAAD type 6 have been reported<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. So far, more than 20
different missense mutations of ACTA2 have been found to be associated with
aortopathies<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.
ACTA2 mutations may show reduced penetrance and variable expressivity due to a
dominant negative mechanism<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Heterozygous ACTA2 mutations may lead to impaired SMCs,
showing pathological hyperplasia and disarray due to medial degeneration,
vascular wall remodeling, increased wall stiffness, and aortic
dilation<sup>[<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref>]</sup>. It may indicate a possible
increased risk of stroke and CAD rather than hypertrophy<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>, and it may be a causative
etiology of multiple tiny aneurysms of the cerebral arteries, responsible for
pediatric acute ischemic stroke<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. The relationship among SMA, ACTA2 gene, and contractile
property in vasculopathies is listed in <xref ref-type="fig" rid="f1">Figure
1</xref>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>The relationship among smooth muscle actin, ACTA2 gene and
contractile property in vasculopathies. The contractility of the
smooth muscle cells is maintained via cyclic interactions between
&#x003b1;-smooth muscle actin (encoded by ACTA2) and the
&#x003b2;-myosin heavy chain (encoded by MYH11). Missense mutations
in ACTA2 and myosin are responsible for the development of syndromic
aneurysms or occlusive vascular disorders, depending on the vascular
pathology of either medial smooth muscle cell hypoplasia or medial
proliferation. ACTA2=actin, alpha 2, smooth muscle, aorta;
CAD=coronary artery disease; MYH11=myosin heavy chain 11; SMA=smooth
muscle actin; SMC=smooth muscle cell; TAAD=thoracic aortic aneurysm
and dissection</p></caption><graphic xlink:href="rbccv-30-06-0644-g01"/></fig>
</p><p>Syndromic aneurysms (Marfan syndrome and other connective tissue diseases
including Loeys-Dietz syndrome, Ehlers-Danlos syndrome, and familial TAAD) have
been proven to have overlapping clinical features and mutated TGF-&#x003b2;
genes<sup>[<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref>]</sup> while familial non-syndromic
patients are associated with mutations in MYH11, transforming growth factor
beta-receptor 1 (TGF&#x003b2;R1), Transforming growth factor beta-receptor 2
(TGF&#x003b2;R2), myosin light chain kinase (MYLK), and ACTA2 genes in spite of
incomplete penetrance and/or locus heterogeneity<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. Casual mutations of fibrillin-1,
TGF&#x003b2;R1, TGF&#x003b2;R2, ACTA2, MYH11, and SMAD3 genes were detected in
TAAD patients<sup>[<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r25" ref-type="bibr">25</xref>,<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><p>A mutation in a single ACTA2 gene can cause a variety of vascular
diseases<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Guo et
al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup> reported that
mutations in ACTA2 gene are the most common mutations, accounting for 10-15% of
familial TAAD mutations. By contrast, only 0.9% of the patients with TAAD had a
mutation in the ACTA2 gene according to Lerner-Ellis et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. The prevalence of ACTA2
mutations was 12-16% in familial TAAD<sup>[<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r29" ref-type="bibr">29</xref>]</sup> as opposed
to 0% in sporadic cases<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.
In patients with known TAAD, non-synonymous missense mutations were identified
in 3.85% probands<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. The
TAAD family members showed a penetrance as low as 0.48% in heterozygous ACTA2
mutations<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>. TAAD
was the primary vascular disease in ACTA2-mutation carriers, some of which also
had premature CAD, ischemic strokes and multiple vascular diseases, including
Moyamoya disease<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r32" ref-type="bibr">32</xref>,<xref rid="r33" ref-type="bibr">33</xref>]</sup>. However, none of the family members without ACTA2
mutation had TAAD, premature CAD or stroke<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Causative gene mutations for TAAD have been
identified, including TGF&#x003b2;R2 at the TAAD2 locus, MYH11 at the 16p locus,
and ACTA2 at the TAAD4 locus<sup>[<xref rid="r34" ref-type="bibr">34</xref>]</sup>. Causative genes responsible for vasculopathies such as
aortic, coronary, peripheral vascular and cerebrovascular disorders were
carefully depicted in <xref ref-type="table" rid="t2">Table 1</xref>
<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r34" ref-type="bibr">34</xref>-<xref rid="r41" ref-type="bibr">41</xref>]</sup>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 1</label><caption><p>Causative ACTA2 gene mutations of vasculopathies.</p></caption><table frame="hsides" rules="all"><thead><tr style="border-bottom-style:solid;border-bottom-width:medium;border-top-style:solid;border-top-width:medium"><th align="left" rowspan="1" colspan="1">Causative gene mutation</th><th align="left" rowspan="1" colspan="1">Typical manifestation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">p.Arg64Lys (c.191G&#x0003e;A) (exon 3), p.Arg179Cys
(c.535C&#x0003e;T) (exon 6) &#x00026; p.Lue244Phe (c.732G&#x0003e;T) (exon
7)</td><td align="left" rowspan="1" colspan="1">TAAD</td><td align="center" rowspan="1" colspan="1">[23]</td></tr><tr><td align="left" rowspan="1" colspan="1">p.Arg179His</td><td align="left" rowspan="1" colspan="1">TAAD</td><td align="center" rowspan="1" colspan="1">[23]</td></tr><tr><td align="left" rowspan="1" colspan="1">G304R (in the vicinity of the ATP-binding
site)</td><td align="left" rowspan="1" colspan="1">TAAD, isolated</td><td align="center" rowspan="1" colspan="1">[20]</td></tr><tr><td align="left" rowspan="1" colspan="1">p.G152_T205del (c.616+1G&#x0003e;T), p.R212Q &#x00026;
p.R149C</td><td align="left" rowspan="1" colspan="1">TAAD, familial</td><td align="center" rowspan="1" colspan="1">[17]</td></tr><tr><td align="left" rowspan="1" colspan="1">p.Y145C</td><td align="left" rowspan="1" colspan="1">TAAD, sporadic &#x00026; young-onset</td><td align="center" rowspan="1" colspan="1">[17]</td></tr><tr><td align="left" rowspan="1" colspan="1">c.76G&#x0003e;T; p.Asp26Tyr</td><td align="left" rowspan="1" colspan="1">TAAD, non-syndromic familial</td><td align="center" rowspan="1" colspan="1">[19]</td></tr><tr><td align="left" rowspan="1" colspan="1">R39C (the DNAse-I-binding loop within subdomain 2
of a-smooth muscle actin)</td><td align="left" rowspan="1" colspan="1">Aortic aneurysm, recurrent</td><td align="center" rowspan="1" colspan="1">[20]</td></tr><tr><td align="left" rowspan="1" colspan="1">M49V (the DNAse-I-binding loop within subdomain 2
of a-smooth muscle actin) R118Q &#x00026; R149C</td><td align="left" rowspan="1" colspan="1">Aortic dissection</td><td align="center" rowspan="1" colspan="1">[20]</td></tr><tr><td align="left" rowspan="1" colspan="1">R118Q &#x00026; R149C</td><td align="left" rowspan="1" colspan="1">Aortic disease, coronary artery disease (early
onset)</td><td align="center" rowspan="1" colspan="1">[15]</td></tr><tr><td align="left" rowspan="1" colspan="1">R258</td><td align="left" rowspan="1" colspan="1">Aortic disease, patent ductus arteriosus,
cerebrovascular disease (very early onset), including Moyamoya
disease</td><td align="center" rowspan="1" colspan="1">[15]</td></tr><tr><td align="left" rowspan="1" colspan="1">R179H</td><td align="left" rowspan="1" colspan="1">Aortic &#x00026; cerebrovascular disease, fixed dilated
pupils, hypotonic bladder, gut malrotation, hypoperistalsis
&#x00026; pulmonary hypertension</td><td align="center" rowspan="1" colspan="1">[15]</td></tr><tr><td align="left" rowspan="1" colspan="1">R179H</td><td align="left" rowspan="1" colspan="1">More severe vasculopathy, thoracic aortic aneurysm
&#x00026; brachial artery occlusion</td><td align="center" rowspan="1" colspan="1">[16,18]</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R118Q, p.R149C</td><td align="left" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R179C amino acid substitution (c.535C&#x0003e;T in
exon 6)</td><td align="left" rowspan="1" colspan="1">Primary pulmonary hypertension, persistent ductus
arteriosus, extensive cerebral white matter lesions, fixed
dilated pupils, intestinal malrotation &#x00026; hypotonic
bladder</td><td align="center" rowspan="1" colspan="1">[31]</td></tr><tr><td align="left" rowspan="1" colspan="1">c.772C/T, p.R258C; c.773 G/A, p.R258H; R179H, c.536
G/R (Exon 6)</td><td align="left" rowspan="1" colspan="1">Moyamoya disease</td><td align="center" rowspan="1" colspan="1">[33]</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R258C/H</td><td align="left" rowspan="1" colspan="1">Strokes</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R39H (SD2 domain)</td><td align="left" rowspan="1" colspan="1">Stroke (before the age of 20)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">R179H substitutions</td><td align="left" rowspan="1" colspan="1">Cerebral developmental defects (underdeveloped
corpus callosum &#x00026; vermis hypoplasia), vascular fragility
&#x00026; ductus arteriosus rupture</td><td align="center" rowspan="1" colspan="1">[31]</td></tr><tr><td align="left" rowspan="1" colspan="1">R179H</td><td align="left" rowspan="1" colspan="1">Neonatal seizures due to multifocal infarcts,
asymmetric motor deficits, global developmental delay,
spasticity, congenital bilateral mydriasis &#x00026; patent ductus
arteriosus</td><td align="center" rowspan="1" colspan="1">[30]</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R149C, p.R118Q &#x00026; p.T353N (within the
hydrophobic cleft of a-smooth muscle actin)</td><td align="left" rowspan="1" colspan="1">Premature coronary artery disease</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R185Q</td><td align="left" rowspan="1" colspan="1">Perturb adenosine triphosphatase hydrolysis</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid;border-bottom-width:medium"><td align="left" rowspan="1" colspan="1">R149C</td><td align="left" rowspan="1" colspan="1">Skin rash caused by dermal capillary and small
artery occlusion referring to as livedo reticularis &#x00026; with
iris flocculi, patent ductus arteriosus &#x00026; bicuspid aortic
valve</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ATP=adenosine triphosphate; TAAD=thoracic aortic aneurysm and
dissection.</p></fn></table-wrap-foot></table-wrap><p>Heterozygous missense mutations in ACTA2 disrupting Arg179 had persistent ductus
arteriosus and congenital mydriasis, variable presentation of pulmonary
hypertension, bladder and gastrointestinal disorders, as well as carotid and
cerebrovascular abnormalities, including absent basal
"Moyamoya"collaterals<sup>[<xref rid="r42" ref-type="bibr">42</xref>]</sup>. MYH11 and ACTA2 missense mutations were associated with
upregulation of the TGF-&#x003b2; signaling pathway<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. Distinct loci for large pedigrees of
familial TAAD were on 5q13-q14, 16p13.12-p13.13, 11q23.3-q24, 3p24-p25, 9q22,
10q22-q24, and 15q24-q26 (MIM 607087, 132900, 607086, 6103080, 608967, 611788,
and unassigned), with four being identified as ACTA2 (MIM 102620, 10q23), MYH11
(MIM160745, 16p13), TGF&#x003b2;R1 (MIM 190181, 9q22), and TGF&#x003b2;R2 (MIM
190182, 3p22)<sup>[<xref rid="r43" ref-type="bibr">43</xref>]</sup>. Patients
presenting with acute ascending or descending aortic dissections have also been
found to have ACTA2 mutations<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Half of the mutation carriers have no aortic disease,
while those with aortic aneurysms usually have missense ACTA2 mutations with
fewer deletions and splice-site mutations<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Aortic aneurysms pending to rupture may show various
aortic dimensions, in particular, patients with aortic aneurysm with ACTA2
mutations have an aortic dimension of &#x0003c;5.0 cm prior to dissection. Therefore,
early surgical treatment is recommended in such patients, even with minimal
changes to aortic dimensions<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Shimojima et al.<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup> sequenced the nine exons of ACTA2 in a cohort of 53
patients with Moyamoya disease from 7 familial series without showing any
mutations. Similarly, Lee et al.<sup>[<xref rid="r45" ref-type="bibr">45</xref>]</sup> also reported that mutations in human RNF213 were present
whereas ACTA2 gene mutations were absent in 36 Taiwanese Moyamoya patients.</p></sec><sec><title>Basic Research for Possible Mechanisms</title><p>&#x003b1;-SMA is important for contractile functions of the developing heart at an
early embryonic stage. Research on avian epimyocardial cells demonstrated
&#x003b1;-SMA mRNAs were mainly detected in conus arteriosus and the ventral
aorta before Hamburger-Hamilton stage (HH) 12. In subsequent stages, the
&#x003b1;-SMA mRNA was apparently confined to SMCs of the vascular system. The
contractive properties of SMCs can be suspended while secretory functions
prevail by exertions of mitogens, including platelet-derived growth factor
(PDGF) and basic fibroblast growth factor (bFGF), and extracellular matrix
components such as collagen, elastin and proteoglycans that contribute to SMC
differentiation and proliferation<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Hence, &#x003b1;-SMA expression inversely correlates with
cell proliferation, but directly correlates with contractile efficiency of
SMCs<sup>[<xref rid="r46" ref-type="bibr">46</xref>]</sup>.</p><p>Fibronectin and laminin are expressed typically in the arterial media during
fetal and adult life in different forms, and a paradoxical transformation of the
proteins from adult to fetal variants takes place during the vascular
pathological processes. Vascular SMCs are also implicated in vessel remodeling,
in either physiological or pathological conditions, such as pregnancy, exercise,
or vascular injury<sup>[<xref rid="r47" ref-type="bibr">47</xref>]</sup>. During
the remodeling process after vascular injury, the SMCs resume a contractile
phenotype, with a cytoplasm dominated by &#x003b1;-actin filaments until the
final extent of neointimal formation. The phenotype of cultured rabbit SMCs can
be modified by PDGF-BB, resulting in faster growth, but SMCs preincubated with
conditioned medium of macrophages plus anti-PDGF antibody did not grow faster.
Human arterial and venous SMCs exhibited very different proliferative responses
to PDGF isoforms. Proliferation of arterial SMCs was strongly stimulated by
PDGF-AA, but venous SMCs showed no proliferative response to PDGF-AA,
demonstrating instead a significantly greater proliferative response to PDGFBB
than arterial SMCs<sup>[<xref rid="r48" ref-type="bibr">48</xref>]</sup>. In
cultured rat aortic SMCs, enhanced proliferation, elongated cellular deformity
as well as a fluctuation pattern of growth under the exertion of
TGF-&#x003b2;<sub>1</sub> were present<sup>[<xref rid="r49" ref-type="bibr">49</xref>]</sup>.</p><p>During angiogenesis and vascular remodeling due to restenosis and
atherosclerosis, SMCs regulate endothelial cell quiescence and angiogenic
responsiveness to cytokines. A series of studies revealed TGF-&#x003b2;
stimulates the matrix production of vascular SMCs, including type I collagen.
The enhanced &#x003b1;-SMA expression induced by TGF-&#x003b2;<sub>1</sub>
increases the contraction of collagen gel mediated by bovine corneal fibroblasts
in a dose-dependent manner. Integrin &#x003b1;<sub>2</sub>&#x003b2;<sub>1</sub>,
one of the collagen-binding receptors, binds fibril-forming collagens, collagens
I, II, III and X. It joins the process of TGF-&#x003b2;<sub>1</sub>-induced
&#x003b1;-SMA production and regulation, capable of generating intracellular
tension.</p><p>&#x003b1;-SMA disruption results in SMC hyperplasia via certain cellular pathways
involving FAK, p53 and PDGF receptor-&#x003b2;, contributing to vascular
occlusive disorders in patients with ACTA2 missense mutations. This is supported
by the experiments in ACTA2 knockout mice, in which decreased aortic
contractility was displayed<sup>[<xref rid="r50" ref-type="bibr">50</xref>]</sup>. The structural heterogeneity of genomic DNA encoding the
chicken &#x003b1;-SMA gene in 3' untranslated regions is of alternative
polyadenylation signals, but with uncertain functional implications. Moreover,
actin isoform synthesis after balloon induced endothelial denudation warrants
further investigations in order to be employed early in clinical practice.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>ACTA2 mutations are associated with structural disruption and functional impairment
of contractile proteins, and predispose to a variety of diffuse vascular diseases
including TAAD, CAD, ischemic strokes, and Moyamoya disease. Vascular SMCs are also
implicated in vascular remodeling in both physiological and pathological conditions.
Regulation of differentiation and proliferation of SMCs may control the expression
of genes encoding for proteins responsible for the contractile function of the SMCs.
In the process of vascular remodeling, contractive properties of SMCs can be
suspended while secretory functions prevail by mitogen impacts. Research on
&#x003b1;-SMA and ACTA2 mutations is imperative for understanding the pathogenesis
and determining the pertinent management strategies of vasculopathies. Further
in-depth studies of causative genes of ACTA2 mutations may largely facilitate the
diagnosis and treatment of the underlying disorders.</p><table-wrap id="t3" orientation="portrait" position="float"><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1">
<bold>Authors' roles &#x00026; responsibilities</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SMY</td><td align="left" rowspan="1" colspan="1">Study conception and design; analysis and/or
interpretation of data; manuscript writing, final approval of the
manuscript.</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at The First Hospital of Putian, Teaching Hospital,
Fujian Medical University, Putian, Fujian Province, People&#x02019;s Republic of
China.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zohar</surname><given-names>R</given-names></name><name><surname>McCulloch</surname><given-names>CA</given-names></name></person-group><article-title>Multiple roles of &#x003b1;-smooth muscle actin in
mechanotransduction</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><issue>13</issue><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">16325810</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Papke</surname><given-names>CL</given-names></name><name><surname>Tran-Fadulu</surname><given-names>V</given-names></name><name><surname>Regalado</surname><given-names>ES</given-names></name><name><surname>Avidan</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Mutations in smooth muscle alpha-actin (ACTA2) cause coronary
artery disease, stroke, and Moyamoya disease, along with thoracic aortic
disease</article-title><source>Am J Hum Genet</source><year>2009</year><volume>84</volume><issue>5</issue><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">19409525</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewicz</surname><given-names>DM</given-names></name><name><surname>Kwartler</surname><given-names>CS</given-names></name><name><surname>Papke</surname><given-names>CL</given-names></name><name><surname>Regalado</surname><given-names>ES</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Reid</surname><given-names>AJ</given-names></name></person-group><article-title>Genetic variants promoting smooth muscle cell proliferation can
result in diffuse and diverse vascular diseases: evidence for a hyperplastic
vasculomyopathy</article-title><source>Genet Med</source><year>2010</year><volume>12</volume><issue>4</issue><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">20130469</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherng</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>Alpha-smooth muscle actin (&#x003b1;-SMA)</article-title><source>J Am Sci</source><year>2008</year><volume>4</volume><fpage>7</fpage><lpage>9</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B</given-names></name><name><surname>Celetta</surname><given-names>G</given-names></name><name><surname>Tomasek</surname><given-names>JJ</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name><name><surname>Chaponnier</surname><given-names>C</given-names></name></person-group><article-title>Alpha-smooth muscle actin expression upregulates fibroblast
contractile activity</article-title><source>Mol Biol Cell</source><year>2001</year><volume>12</volume><issue>9</issue><fpage>2730</fpage><lpage>2741</lpage><pub-id pub-id-type="pmid">11553712</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>JH</given-names></name><name><surname>Yoon</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HW</given-names></name><name><surname>Jo</surname><given-names>KH</given-names></name></person-group><article-title>Adventitial fibroblast abnormality in thoracic aortic aneurysms
and aortic dissections</article-title><source>Korean J Thorac Cardiovasc Surg</source><year>2011</year><volume>44</volume><issue>6</issue><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">22324025</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schildmeyer</surname><given-names>LA</given-names></name><name><surname>Braun</surname><given-names>R</given-names></name><name><surname>Taffet</surname><given-names>G</given-names></name><name><surname>Debiasi</surname><given-names>M</given-names></name><name><surname>Burns</surname><given-names>AE</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impaired vascular contractility and blood pressure homeostasis in
the smooth muscle alpha-actin null mouse</article-title><source>FASEB J</source><year>2000</year><volume>14</volume><issue>14</issue><fpage>2213</fpage><lpage>2220</lpage><pub-id pub-id-type="pmid">11053242</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Ryschich</surname><given-names>E</given-names></name><name><surname>Schumacher</surname><given-names>H</given-names></name><name><surname>Allenberg</surname><given-names>JR</given-names></name></person-group><article-title>Increased apoptosis and decreased density of medial smooth muscle
cells in human abdominal aortic aneurysms</article-title><source>Chin Med J (Eng)</source><year>2003</year><volume>116</volume><issue>10</issue><fpage>1549</fpage><lpage>1552</lpage></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virmani</surname><given-names>R</given-names></name><name><surname>Kolodgie</surname><given-names>FD</given-names></name><name><surname>Burke</surname><given-names>AP</given-names></name><name><surname>Finn</surname><given-names>AV</given-names></name><name><surname>Gold</surname><given-names>HK</given-names></name><name><surname>Tulenko</surname><given-names>TN</given-names></name><etal/></person-group><article-title>Atherosclerotic plaque progression and vulnerability to rupture:
angiogenesis as a source of intraplaque hemorrhage</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><issue>10</issue><fpage>2054</fpage><lpage>2061</lpage><pub-id pub-id-type="pmid">16037567</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tondeleir</surname><given-names>D</given-names></name><name><surname>Vandamme</surname><given-names>D</given-names></name><name><surname>Vandekerckhove</surname><given-names>J</given-names></name><name><surname>Ampe</surname><given-names>C</given-names></name><name><surname>Lambrechts</surname><given-names>A</given-names></name></person-group><article-title>Actin isoform expression patterns during mammalian development
and in pathology: insights from mouse models</article-title><source>Cell Motil Cytoskeleton</source><year>2009</year><volume>66</volume><issue>10</issue><fpage>798</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">19296487</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassef</surname><given-names>M</given-names></name><name><surname>Baxter</surname><given-names>BT</given-names></name><name><surname>Chisholm</surname><given-names>RL</given-names></name><name><surname>Dalman</surname><given-names>RL</given-names></name><name><surname>Fillinger</surname><given-names>MF</given-names></name><name><surname>Heinecke</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pathogenesis of abdominal aortic aneurysms: a multidisciplinary
research program supported by the National Heart, Lung, and Blood
Institute</article-title><source>J Vasc Surg</source><year>2001</year><volume>34</volume><issue>4</issue><fpage>730</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">11668331</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Papke</surname><given-names>CL</given-names></name><name><surname>He</surname><given-names>R</given-names></name><name><surname>Milewicz</surname><given-names>DM</given-names></name></person-group><article-title>Pathogenesis of thoracic and abdominal aortic
aneurysms</article-title><source>Ann N Y Acad Sci</source><year>2006</year><volume>1085</volume><fpage>339</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">17182954</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name><name><surname>Camenzind</surname><given-names>E</given-names></name><name><surname>Bacchetta</surname><given-names>M</given-names></name><name><surname>Virmani</surname><given-names>R</given-names></name><name><surname>Bochaton-Piallat</surname><given-names>ML</given-names></name></person-group><article-title>Phenotypic modulation of intima and media smooth muscle cells in
fatal cases of coronary artery lesion</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2006</year><volume>26</volume><issue>2</issue><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">16339500</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingley</surname><given-names>JA</given-names></name><name><surname>Hayward</surname><given-names>IP</given-names></name><name><surname>Campbell</surname><given-names>GR</given-names></name><name><surname>Campbell</surname><given-names>JH</given-names></name></person-group><article-title>Relationship of glycosaminoglycan and matrix changes to vascular
smooth muscle cell phenotype modulation in rabbit arteries after acute
injury</article-title><source>J Vasc Surg</source><year>2001</year><volume>33</volume><issue>1</issue><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">11137936</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toma</surname><given-names>N</given-names></name><name><surname>Matsushima</surname><given-names>S</given-names></name><name><surname>Murao</surname><given-names>K</given-names></name><name><surname>Kawaguchi</surname><given-names>K</given-names></name><name><surname>Imanaka-Yoshida</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><etal/></person-group><article-title>Histopathological findings in a human carotid artery after stent
implantation. Case report</article-title><source>J Neurosurg</source><year>2003</year><volume>98</volume><issue>1</issue><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">12546374</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukui</surname><given-names>D</given-names></name><name><surname>Miyagawa</surname><given-names>S</given-names></name><name><surname>Soeda</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Urayama</surname><given-names>H</given-names></name><name><surname>Kawasaki</surname><given-names>S</given-names></name></person-group><article-title>Overexpression of transforming growth factor &#x000df;1 in smooth
muscle cells of human abdominal aortic aneurysm</article-title><source>Eur J Vasc Endovasc Surg</source><year>2003</year><volume>25</volume><issue>6</issue><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">12787696</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>John Welsh Cardiovascular Diagnostic Laboratory</collab></person-group><source>ACTA2 mutation analysis</source><date-in-citation content-type="access-date">2015 Jul 10</date-in-citation><comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.bcm.edu/departments/pediatrics/cardiology/acta2">https://www.bcm.edu/departments/pediatrics/cardiology/acta2</ext-link></comment></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergeron</surname><given-names>SE</given-names></name><name><surname>Wedemeyer</surname><given-names>EW</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Wen</surname><given-names>KK</given-names></name><name><surname>McKane</surname><given-names>M</given-names></name><name><surname>Pierick</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Allele-especific effects of thoracic aortic aneurysm and
dissection &#x003b1;-smooth muscle actin mutations on actin
function</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><issue>13</issue><fpage>11356</fpage><lpage>11369</lpage><pub-id pub-id-type="pmid">21288906</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Kamm</surname><given-names>KE</given-names></name><name><surname>Regalado</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mutations in myosin light chain kinase cause familial aortic
dissections</article-title><source>Am J Hum Genet</source><year>2010</year><volume>87</volume><issue>5</issue><fpage>701</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">21055718</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mohaissen</surname><given-names>M</given-names></name><name><surname>Allanson</surname><given-names>JE</given-names></name><name><surname>O'Connor</surname><given-names>MD</given-names></name><name><surname>Veinot</surname><given-names>JP</given-names></name><name><surname>Brandys</surname><given-names>TM</given-names></name><name><surname>Maharajh</surname><given-names>G</given-names></name><etal/></person-group><article-title>Brachial artery occlusion in a young adult with an ACTA2 thoracic
aortic aneurysm</article-title><source>Vasc Med</source><year>2012</year><volume>17</volume><issue>5</issue><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">22946110</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Disabella</surname><given-names>E</given-names></name><name><surname>Grasso</surname><given-names>M</given-names></name><name><surname>Gambarin</surname><given-names>FI</given-names></name><name><surname>Narula</surname><given-names>N</given-names></name><name><surname>Dore</surname><given-names>R</given-names></name><name><surname>Favalli</surname><given-names>V</given-names></name><etal/></person-group><article-title>Risk of dissection in thoracic aneurysms associated with
mutations of smooth muscle &#x003b1;-actin 2 (ACTA2)</article-title><source>Heart</source><year>2011</year><volume>97</volume><issue>4</issue><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">21212136</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amans</surname><given-names>MR</given-names></name><name><surname>Stout</surname><given-names>C</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Narvid</surname><given-names>J</given-names></name><name><surname>Hetts</surname><given-names>SW</given-names></name><name><surname>Cooke</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Cerebral arteriopathy associated with Arg179His ACTA2
mutation</article-title><source>BMJ Case Rep</source><year>2013</year><volume>29</volume><fpage>2013</fpage><lpage>2013</lpage></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jondeau</surname><given-names>G</given-names></name><name><surname>Boileau</surname><given-names>C</given-names></name></person-group><article-title>Genetics of thoracic aortic aneurysms</article-title><source>Curr Atheroscler Rep</source><year>2012</year><volume>14</volume><issue>3</issue><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">22415348</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomianowski</surname><given-names>P</given-names></name><name><surname>Elefteriades</surname><given-names>JA</given-names></name></person-group><article-title>The genetics and genomics of thoracic aortic
disease</article-title><source>Ann Cardiothorac Surg</source><year>2013</year><volume>2</volume><issue>3</issue><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">23977594</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proost</surname><given-names>D</given-names></name><name><surname>Vandeweyer</surname><given-names>G</given-names></name><name><surname>Meester</surname><given-names>JA</given-names></name><name><surname>Salemink</surname><given-names>S</given-names></name><name><surname>Kempers</surname><given-names>M</given-names></name><name><surname>Ingram</surname><given-names>C</given-names></name><etal/></person-group><article-title>Performant mutation identification using targeted next generation
sequencing of fourteen thoracic aortic aneurysm genes</article-title><source>Hum Mutat</source><year>2015</year><volume>36</volume><issue>8</issue><fpage>808</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">25907466</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>SM</given-names></name><name><surname>Shikany</surname><given-names>A</given-names></name><name><surname>Landis</surname><given-names>BJ</given-names></name><name><surname>James</surname><given-names>JF</given-names></name><name><surname>Hinton</surname><given-names>RB</given-names></name></person-group><article-title>Twins with progressive thoracic aortic aneurysm, recurrent
dissection and ACTA2 mutation</article-title><source>Pediatrics</source><year>2014</year><volume>134</volume><issue>4</issue><fpage>e1218</fpage><lpage>e1223</lpage><pub-id pub-id-type="pmid">25225139</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Pannu</surname><given-names>H</given-names></name><name><surname>Tran-Fadulu</surname><given-names>V</given-names></name><name><surname>Papke</surname><given-names>CL</given-names></name><name><surname>Yu</surname><given-names>RK</given-names></name><name><surname>Avidan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mutations in smooth muscle &#x003b1;-actin (ACTA2) lead to
thoracic aortic aneurysms and dissections</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><issue>12</issue><fpage>1488</fpage><lpage>1493</lpage><pub-id pub-id-type="pmid">17994018</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner-Ellis</surname><given-names>JP</given-names></name><name><surname>Aldubayan</surname><given-names>SH</given-names></name><name><surname>Hernandez</surname><given-names>AL</given-names></name><name><surname>Kelly</surname><given-names>MA</given-names></name><name><surname>Stuenkel</surname><given-names>AJ</given-names></name><name><surname>Walsh</surname><given-names>J</given-names></name><etal/></person-group><article-title>The spectrum of FBN1, TGF&#x000df;R1, TGF&#x000df;R2 and ACTA2
variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz
Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD)</article-title><source>Mol Genet Metab</source><year>2014</year><volume>112</volume><issue>2</issue><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">24793577</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renard</surname><given-names>M</given-names></name><name><surname>Callewaert</surname><given-names>B</given-names></name><name><surname>Baetens</surname><given-names>M</given-names></name><name><surname>Campens</surname><given-names>L</given-names></name><name><surname>MacDermot</surname><given-names>K</given-names></name><name><surname>Fryns</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Novel MYH11 and ACTA2 mutations reveal a role for enhanced
TGF&#x000df; signaling in FTAAD</article-title><source>Int J Cardiol</source><year>2013</year><volume>165</volume><issue>2</issue><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">21937134</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Arno</surname><given-names>G</given-names></name><name><surname>Aragon-Martin</surname><given-names>JA</given-names></name><name><surname>Harris</surname><given-names>S</given-names></name><etal/></person-group><source>Mutations in ACTA2 in a British cohort of TAAD patients</source><date-in-citation content-type="access-date">2015 Jul 10</date-in-citation><comment>a Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ichg2011.org/abstracts/fulltext/f11027.htm">http://www.ichg2011.org/abstracts/fulltext/f11027.htm</ext-link></comment></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewicz</surname><given-names>DM</given-names></name><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Tran-Fadulu</surname><given-names>V</given-names></name><name><surname>Lafont</surname><given-names>AL</given-names></name><name><surname>Papke</surname><given-names>CL</given-names></name><name><surname>Inamoto</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetic basis of thoracic aortic aneurysms and dissections: focus
on smooth muscle cell contractile dysfunction</article-title><source>Annu Rev Genomics Hum Genet</source><year>2008</year><volume>9</volume><fpage>283</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">18544034</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffjan</surname><given-names>S</given-names></name></person-group><article-title>Genetic dissection of Marfan syndrome and related connective
tissue disorders: an update 2012</article-title><source>Mol Syndromol</source><year>2012</year><volume>3</volume><issue>2</issue><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">23326250</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Katerina</surname><given-names>L</given-names></name></person-group><source>Byanova. Effects of the ACTA2 R258C mutation on vascular smooth muscle
cell phenotype and properties. UT GSBS Dissertations and Theses</source><date-in-citation content-type="access-date">2015 Jul 10</date-in-citation><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://digitalcommons.library.tmc.edu/utgsbs_dissertations/248/">http://digitalcommons.library.tmc.edu/utgsbs_dissertations/248/</ext-link></comment></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mohaissen</surname><given-names>M</given-names></name><name><surname>Allanson</surname><given-names>JE</given-names></name><name><surname>O'Connor</surname><given-names>MD</given-names></name><name><surname>Veinot</surname><given-names>JP</given-names></name><name><surname>Brandys</surname><given-names>TM</given-names></name><name><surname>Maharajh</surname><given-names>G</given-names></name><etal/></person-group><article-title>Brachial artery occlusion in a young adult with an ACTA2 thoracic
aortic aneurysm</article-title><source>Vasc Med</source><year>2012</year><volume>17</volume><issue>5</issue><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">22946110</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewicz</surname><given-names>DM</given-names></name><name><surname>&#x000d8;stergaard</surname><given-names>JR</given-names></name><name><surname>Ala-Kokko</surname><given-names>LM</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Grange</surname><given-names>DK</given-names></name><name><surname>Mendoza-Londono</surname><given-names>R</given-names></name><etal/></person-group><article-title>De novo ACTA2 mutation causes a novel syndrome of multisystemic
smooth muscle dysfunction</article-title><source>Am J Med Genet A</source><year>2010</year><volume>152A</volume><issue>10</issue><fpage>2437</fpage><lpage>2443</lpage><pub-id pub-id-type="pmid">20734336</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morisaki</surname><given-names>H</given-names></name><name><surname>Akutsu</surname><given-names>K</given-names></name><name><surname>Ogino</surname><given-names>H</given-names></name><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Yamanaka</surname><given-names>I</given-names></name><name><surname>Tsutsumi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Mutation of ACTA2 gene as an important cause of familial and
nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection
(TAAD)</article-title><source>Hum Mutat</source><year>2009</year><volume>30</volume><issue>10</issue><fpage>1406</fpage><lpage>1411</lpage><pub-id pub-id-type="pmid">19639654</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>EH</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Jang</surname><given-names>SY</given-names></name><name><surname>Suh</surname><given-names>YL</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Song</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Clinical, pathological, and genetic analysis of a Korean family
with thoracic aortic aneurysms and dissections carrying a novel Asp26Tyr
mutation</article-title><source>Ann Clin Lab Sci</source><year>2010</year><volume>40</volume><issue>3</issue><fpage>278</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">20689142</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffjan</surname><given-names>S</given-names></name><name><surname>Waldm&#x000fc;ller</surname><given-names>S</given-names></name><name><surname>Blankenfeldt</surname><given-names>W</given-names></name><name><surname>K&#x000f6;tting</surname><given-names>J</given-names></name><name><surname>Gehle</surname><given-names>P</given-names></name><name><surname>Binner</surname><given-names>P</given-names></name><etal/></person-group><article-title>Three novel mutations in the ACTA2 gene in German patients with
thoracic aortic aneurysms and dissections</article-title><source>Eur J Hum Genet</source><year>2011</year><volume>19</volume><issue>5</issue><fpage>520</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">21248741</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moosa</surname><given-names>AN</given-names></name><name><surname>Traboulsi</surname><given-names>EI</given-names></name><name><surname>Reid</surname><given-names>J</given-names></name><name><surname>Prieto</surname><given-names>L</given-names></name><name><surname>Moran</surname><given-names>R</given-names></name><name><surname>Friedman</surname><given-names>NR</given-names></name></person-group><article-title>Neonatal stroke and progressive leukoencephalopathy in a child
with an ACTA2 mutation</article-title><source>J Child Neurol</source><year>2013</year><volume>28</volume><issue>4</issue><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">22752479</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meuwissen</surname><given-names>ME</given-names></name><name><surname>Lequin</surname><given-names>MH</given-names></name><name><surname>Bindels-de Heus</surname><given-names>K</given-names></name><name><surname>Bruggenwirth</surname><given-names>HT</given-names></name><name><surname>Knapen</surname><given-names>MF</given-names></name><name><surname>Dalinghaus</surname><given-names>M</given-names></name><etal/></person-group><article-title>ACTA2 mutation with childhood cardiovascular, autonomic and brain
anomalies and severe outcome</article-title><source>Am J Med Genet A</source><year>2013</year><volume>161A</volume><issue>6</issue><fpage>1376</fpage><lpage>1380</lpage><pub-id pub-id-type="pmid">23613326</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roder</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>V</given-names></name><name><surname>Kasuya</surname><given-names>H</given-names></name><name><surname>Nishizawa</surname><given-names>T</given-names></name><name><surname>Wakita</surname><given-names>S</given-names></name><name><surname>Berg</surname><given-names>D</given-names></name><etal/></person-group><article-title>Analysis of ACTA2 in European Moyamoya disease
patients</article-title><source>Eur J Paediatr Neurol</source><year>2011</year><volume>15</volume><issue>2</issue><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">20970362</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munot</surname><given-names>P</given-names></name><name><surname>Saunders</surname><given-names>DE</given-names></name><name><surname>Milewicz</surname><given-names>DM</given-names></name><name><surname>Regalado</surname><given-names>ES</given-names></name><name><surname>Ostergaard</surname><given-names>JR</given-names></name><name><surname>Braun</surname><given-names>KP</given-names></name><etal/></person-group><article-title>A novel distinctive cerebrovascular phenotype is associated with
heterozygous Arg179 ACTA2 mutations</article-title><source>Brain</source><year>2012</year><volume>135</volume><issue>8</issue><fpage>2506</fpage><lpage>2514</lpage><pub-id pub-id-type="pmid">22831780</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>SK</given-names></name><name><surname>LeMaire</surname><given-names>SA</given-names></name><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Russell</surname><given-names>L</given-names></name><name><surname>Regalado</surname><given-names>ES</given-names></name><name><surname>Golabbakhsh</surname><given-names>H</given-names></name><etal/></person-group><article-title>Rare copy number variants disrupt genes regulating vascular
smooth muscle cell adhesion and contractility in sporadic thoracic aortic
aneurysms and dissections</article-title><source>Am J Hum Genet</source><year>2010</year><volume>87</volume><issue>6</issue><fpage>743</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">21092924</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimojima</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name></person-group><article-title>ACTA2 is not a major disease-causing gene for moyamoya
disease</article-title><source>J Hum Genet</source><year>2009</year><volume>54</volume><issue>11</issue><fpage>687</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">19745835</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Chen</surname><given-names>YF</given-names></name><name><surname>Fan</surname><given-names>PC</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mutation genotypes of RNF213 gene from moyamoya patients in
Taiwan</article-title><source>J Neurol Sci</source><year>2015</year><volume>353</volume><issue>1-2</issue><fpage>161</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">25956231</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B</given-names></name><name><surname>Celetta</surname><given-names>G</given-names></name><name><surname>Tomasek</surname><given-names>JJ</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name><name><surname>Chaponnier</surname><given-names>C</given-names></name></person-group><article-title>Alpha-smooth muscle actin expression upregulates fibroblast
contractile activity</article-title><source>Mol Biol Cell</source><year>2001</year><volume>12</volume><issue>9</issue><fpage>2730</fpage><lpage>2741</lpage><pub-id pub-id-type="pmid">11553712</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>GK</given-names></name><name><surname>Kumar</surname><given-names>MS</given-names></name><name><surname>Wamhoff</surname><given-names>BR</given-names></name></person-group><article-title>Molecular regulation of vascular smooth muscle cell
differentiation in development and disease</article-title><source>Physiol Rev</source><year>2004</year><volume>84</volume><issue>3</issue><fpage>767</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">15269336</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Blumenthal</surname><given-names>DK</given-names></name><name><surname>Terry</surname><given-names>CM</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Carlson</surname><given-names>ML</given-names></name><name><surname>Cheung</surname><given-names>AK</given-names></name></person-group><article-title>PDGF-induced proliferation in human arterial and venous smooth
muscle cells: molecular basis for differential effects of PDGF
isoforms</article-title><source>J Cell Biochem</source><year>2011</year><volume>112</volume><issue>1</issue><fpage>289</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">21069732</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orlandi</surname><given-names>A</given-names></name><name><surname>Ropraz</surname><given-names>P</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name></person-group><article-title>Proliferative activity and a-smooth muscle actin expression in
cultured rat aortic smooth muscle cells are differently modulated by
transforming growth factor-&#x000df;1 and heparin</article-title><source>Exp Cell Res</source><year>1994</year><volume>214</volume><issue>2</issue><fpage>528</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">7925646</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schildmeyer</surname><given-names>LA</given-names></name><name><surname>Braun</surname><given-names>R</given-names></name><name><surname>Taffet</surname><given-names>G</given-names></name><name><surname>Debiasi</surname><given-names>M</given-names></name><name><surname>Burns</surname><given-names>AE</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impaired vascular contractility and blood pressure homeostasis in
the smooth muscle &#x003b1;-actin null mouse</article-title><source>FASEB J</source><year>2000</year><volume>14</volume><issue>14</issue><fpage>2213</fpage><lpage>2220</lpage><pub-id pub-id-type="pmid">11053242</pub-id></element-citation></ref></ref-list></back></article>